Brief: Crescita Signs Exclusive Distribution Agreement With Fillmed
Jan 20 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT WITH
FILLMED
* CRESCITA - ENTERED AGREEMENT WITH LABORATOIRES FILLMED FOR
EXCLUSIVE DISTRIBUTION OF ART-FILLER INJECTABLES RANGE, NEW
CELLULAR TREATMENT FACTOR IN CANADA
* CRESCITA THERAPEUTICS - SEES LAUNCHING BOTH PRODUCTS ON
CANADIAN
MARKET FOLLOWING APPROVAL BY HEALTH CANADA ANTICIPATED BY LATE
2020 OR EARLY 2021
Source text for Eikon: ID:nCNWzxrdRa
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium